Ofstead & Associates, Inc.
Biofilm: A slimy microbial community that lives on medical devices
|Access Date||Quiz Result||Score||Actions|
Eligible for 1.0 contact hour | HSPA | CBSPD | RN |
Soil, bioburden, biofilm… What does it mean for your sterile processing department? Biofilm adheres to surfaces, resists cleaning and disinfection efforts, and can foster antibiotic resistance. In this webinar, two presenters with expertise in epidemiology and microbiology explain the different types of residual organic debris that can be left behind due to inadequate reprocessing. They will discuss study findings and outbreak investigations and explore the possible roles of residual soil, damage, and retained moisture in biofilm development. Participants will learn how to develop and implement multifaceted policies and workflows to address factors contributing to biofilm formation in their departments.
By the end of this webinar, participants will be able to:
- Explain the difference between soil, bioburden, and biofilm
- Discuss the impact of biofilm on reprocessing effectiveness for reusable medical instruments
- Describe the role of process controls, visual inspection, cleaning verification, and microbial surveillance in preventing biofilm-related problems
- List strategies for reducing biofilm and improving reprocessing outcomes
- Differences between soil, bioburden, and biofilm
- Clinical implications of biofilm on medical devices
- Theory and evidence on reprocessing effectiveness
- Reprocessing challenges that contribute to biofilm
- Strategies for improving practices and reducing biofilm
- Sponsor acknowledgement (Supported by an educational grant from Healthmark)
Cori L. Ofstead, MSPH
President & CEO, Ofstead & Associates
Cori L. Ofstead, MSPH, is an epidemiologist with 30 years of experience designing and conducting studies about the impact of clinical processes on patient outcomes. She has served as the Principal Investigator on numerous studies related to infection prevention, instrument reprocessing, and vaccination against infectious diseases. Ms. Ofstead is nationally recognized for her groundbreaking research, and her studies have been published in peer-reviewed journals including CHEST, AJIC, ICHE, Journal of Hospital Infection, Gastroenterology Nursing, and Vaccine. She currently serves as a reviewer for AJIC, Endoscopy, and the Journal of Urology, and is an active member of the editorial board for AJIC. She has presented the findings of her studies at national and international conferences sponsored by the CDC, APIC, IAHCSMM, AORN, SGNA, AGA, and several universities. In addition, she currently serves as a preceptor for epidemiology students in the School of Public Health at the University of Minnesota.
Krystina M. Hopkins, MPH
Research Manager, Ofstead & Associates
Krystina Hopkins is a research manager with Ofstead & Associates, Inc. where she leads projects related to reprocessing effectiveness and environmental health, including chronic conditions, vaccination, radiation hygiene, and healthcare costs. She has an MPH in environmental health, specializing in infectious disease. Her research has been published in AJIC, ICHE, Endoscopy International Open, Journal of Wound Care, Urology, AORN Journal, BI&T (AAMI's journal), and HSPA's PROCESS magazine. Ms. Hopkins has over fourteen years of hands-on health and healthcare-related research experience in diverse in-patient and outpatient settings. Prior to joining Ofstead in 2017, she supported clinical trials in environmental health, health economics, and community-based research as a research project manager at Medica Research Institute. Ms. Hopkins was also involved with projects related to molecular and microbiology, epidemiology, infectious disease, and occupational health in various roles at the University of Minnesota and the Minnesota Department of Health.